Trials / Completed
CompletedNCT00413751
Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (planned)
- Sponsor
- Walter Reed Army Medical Center · Federal
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) |
Timeline
- First posted
- 2006-12-20
- Last updated
- 2006-12-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00413751. Inclusion in this directory is not an endorsement.